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Abstract In modulated electrohyperthermia (mEHT) the
enrichment of electric field and the concomitant heat
can selectively induce cell death in malignant tumors
as a result of elevated glycolysis, lactate production
(Warburg effect), and reduced electric impedance in
cancer compared to normal tissues. Earlier, we showed
in HT29 colorectal cancer xenografts that the mEHT-
provoked programmed cell death was dominantly cas-
pase independent and driven by apoptosis inducing fac-
tor activation. Using this model here, we studied the
mEHT-related cell stress 0-, 1-, 4-, 8-, 14-, 24-, 48-,
72-, 120-, 168- and 216-h post-treatment by focusing on
damage-associated molecular pattern (DAMP) signals.
Significant cell death response upon mEHT treatment
was accompanied by the early upregulation (4-h post-
treatment) of heat shock protein (Hsp70 and Hsp90)
mRNA levels. In situ, the treatment resulted in spatio-
temporal occurrence of a DAMP protein signal sequence
featured by the significant cytoplasmic to cell membrane
translocation of calreticulin at 4 h, Hsp70 between 14
and 24 h and Hsp90 between 24- and 216-h post-
treatment. The release of high-mobility group box1 pro-
tein (HMGB1) from tumor cell nuclei from 24-h post-
treatment and its clearance from tumor cells by 48 h
was also detected. Our results suggest that mEHT treat-
ment can induce a DAMP-related signal sequence in
colorectal cancer xenografts that may be relevant for
promoting immunological cell death response, which
need to be further tested in immune-competent animals.
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Introduction
Modulated electrohyperthermia (mEHT) is a non-invasive
local technique using capacitive coupled 13.56-MHz radio-
frequency for targeted destruction of tumor cells (Andocs
et al. 2009a) based on the elevated conductivity, permittivity,
and current density in cancer compared to normal tissue
(Andocs et al. 2009b; Blad and Baldetorp 1996; Blad et al.
1999; Fiorentini and Szasz 2006; Zou and Guo 2003). We
have previously revealed that mEHTat <42 °C can dominant-
ly induce a caspase-independent programmed cell death in
HT29 colorectal cancer xenografts as a result of cell stress
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synergistically induced by the electric field and heat (Andocs
et al. 2009a; Meggyeshazi et al. 2014). Other groups have
demonstrated that mild whole-body hyperthermia of tumors
between ~38 and 42 °C can generate immunogenic host
response (Frey et al. 2012; Mace et al. 2012) and local hyper-
thermia can cause heat shock protein (Hsp) 70 increment
along with high-mobility group box 1 (HMGB1) protein
release due to stress and necrosis (Frey et al. 2012;
Multhoff et al. 2012; Schildkopf et al. 2010). These
signs were suggestive of programmed cell death-related
damage signals which may lead to immunogenic tumor
cell death (ICD) (Garg et al. 2013).
The spatiotemporal appearance of the so-called
damage-associated molecular pattern (DAMP) signals
can promote the uptake of tumor antigens by antigen
presenting cells and lead to ICD (D’Eliseo et al. 2013;
Garg et al. 2012; Kepp et al. 2011; Ladoire et al. 2013;
Scheffer et al. 2003; Ullrich et al. 2008). The danger
signals combined with cancer antigens can stimulate the
maturation of antigen presenting cells, which finally
“cross prime” and activate anti-tumor T cell immunity
(Kepp et al. 2011; Sachamitr and Fairchild 2012). The
DAMP sequence, relevant to induce ICD in tumor cells,
include the pre-apoptot ic surface exposure of
calreticulin, the surface appearance of heat shock pro-
teins (Hsp70 and Hsp90) and ATP release at early
apoptotic stages, followed by passive release of high-
mobility group box 1 (HMGB1) as well as Hsp70 and
Hsp90 at the late stages (D’Eliseo et al. 2013; Garg
et al. 2010, 2012, 2013; Kepp et al. 2011; Ladoire et al.
2013; Martins et al. 2012). ICD is known to be pro-
voked by massive cell stress in synergy with pro-
grammed cell death (D’Eliseo et al. 2013; Kepp et al.
2009; Krysko et al. 2013; Ladoire et al. 2013) using
chemotherapeutic agents (doxorubicin, oxaliplatin, etc.)
(Ladoire et al. 2013; Tesniere et al. 2010), cardiac
glycosides (Menger et al. 2012), hypericin-based photody-
namic therapy (Castano et al. 2006; Garg et al. 2012; Mroz
et al. 2011) or capsaicin (D’Eliseo et al. 2013). It is of note,
however, that these interventions can generate slightly differ-
ent DAMP patterns (Garg et al. 2013; Kroemer et al. 2013).
This is a feasibility study to see if mEHT can pro-
voke DAMP-related signals in our HT29 colorectal can-
cer xenograft model. Proving such effect can facilitate
the testing of direct correlations between mEHT-induced
DAMP signals and ICD in immune-competent animal
models and would support the rationale of using mEHT
as a supplemental therapy with chemotherapy, as it has
already been used with benefit for treating recurrent
breast cancer, glioblastoma multiforme, and colorectal
cancer metastases to the liver, based mainly on empiri-
cal observations (Feyerabend et al. 2001; Fiorentini
et al. 2006; Hager et al. 1999).
Material and methods
Animal model and treatment
Six to eight-week old Balb/c (nu/nu) mice were subcu-
taneously injected into both femoral regions with 0.1-ml
suspension of 107/ml HT29 tumor cells, grown in
DMEM + GlutaMAX, high-glucose (4.5 g/l) medium,
as described before (Meggyeshazi et al. 2014). Local
mEHT in the right leg of animals were delivered using
plan-parallel electric condenser of the circuit in asym-
metrical electrode arrangement on day-18 of tumor in-
jection when symmetrical tumors measured ~1.5-cm di-
ameter. A rectangular grounded (lower) aluminum elec-
trode of 72.0 cm2, kept at 37 °C during was below the
animals and a 2.5 cm2 round copper–silver–tin-coated
flexible textile electrode (Lorix Ltd. Bajna, Hungary)
was overlaid on the tumors, which were cooled under
control using a wet pad. Electromagnetic heating was
generated by capacitive coupled, amplitude-modulated
13.56 MHz radiofrequency (LabEHY, Oncotherm Kft,
Paty, Hungary).
Under 100 mg/kg ketamine and 10 mg/kg xylazine
anesthesia, 33 animals were treated with a single shot of
mEHT for 30 min using 4-W average power.
Intratumoral temperature was kept at ~42 °C (±0.5 °C)
as measured with optical sensors (Luxtron FOT Lab Kit,
LumaSense Technologies, Inc. CA). The subcutaneous
temperature under the electrode was kept at ~40 °C and
the rectal temperature at ~37 °C. Samples were collect-
ed 0, 1, 4, 8, 14, 24, 48, 72, 120, 168, and 216 h after
treatment from three mice in each group. Also, five
tumor implanted sham-treated animals were sacrificed
24- and 72-h post-treatment. One half of the excised
tumor was fresh frozen in liquid nitrogen and kept at
−80 °C. The other half was fixed in 10 % formalin,
dehydrated, and embedded into paraffin wax (FFPE).
The study was approved by the Governmental Ethical
Committee under No. 22.1/609/001/2010.
mRNA expression microarray analysis
Total RNA isolation and RNA quality control
Frozen tissue sections were prepared from the 4-h post-
treatment treated and untreated samples together with the
24-h sham-treated controls. Total RNA was extracted by
Roche MagNA Pure LC RNA Isolation Tissue Kit (Roche,
Basel, Switzerland). RNA concentration was measured by
NanoDrop instrument (Thermo Scientific, Rockford, IL,
USA). The quality of the nucleic acid was determined with
microcapillary electrophoresis system using Agilent
Bioana lyzer 6000 Pico LabChip k i t (Al igent
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Technologies, Santa Clara, CA, USA). With RNA in-
tegrity number above 7 (RIN >7) 100 ng total RNA
from each sample were mixed and 250 ng pooled total
RNA was amplified and labeled in each group.
Microarray analysis
The recommendation of minimum information about a
microarray experiment (MIAME) guideline was
followed (Brazma et al. 2001). Amplification and la-
beling of the transcripts was performed by using
Affymetrix 3′ IVT Express Kit (Affymetrix, Santa
Clara, CA, USA). Samples were hybridized on
HGU133 Plus 2.0 arrays (Affymetrix) at 45 °C for
16 h. The microarrays were washed and stained on
Fluidics Station 450 device (Affymetrix) using the
vendors kit with the FS450_001 wash protocol. Fluo-
rescent signals were detected by Gene Chip Scanner
3000 (Affymetrix) following the antibody-based signal
amplification with streptavidin–phycoerythrin accord-
ing to manufacturer’s instructions.
From the CEL files, quality control and RNA digestion
plots were generated in R-environment using the
Bioconductor system. The differentially expressed genes be-
tween the analyzed sample groups were determined by signif-
icance analysis of microarrays (SAM) at the significance level
of p<0.05. Feature selections were done according to the
log2FC (log2 fold change) values to select at least twofold
up/downregulated genes.
The row datasets mRNA expression in mEHT-treated
HT29 xenografts are available in the Gene Expression Omni-
bus databank for further analysis (http://www.ncbi.nlm.nih.
gov/geo/), series accession number: GSE58750.
Apoptosis array
Proteins were isolated from the frozen samples using extrac-
tion buffer (20-mM Tris, 2-mM EDTA, 150-mM NaCl, 1 %
Triton-X100, 10 μl/ml phosphatase inhibitor and 5 μl/ml
proteinase inhibitors) for 30 min on ice, followed by centrifu-
gation at 15,000 rpm at 4 °C for 15 min. Lysates were
prepared from the 8-, 14-, and 24-h-treated and 24-h sham-
treated samples and the protein concentration set up for
100 μg/μl based on the Bradford assay. The expression of
35 apoptosis-related proteins was tested using a nitrocellulose
membrane Proteome Profiler™ Human Apoptosis Array Kit
array (R&D, Minneapolis, MN). Arrays were incubated on a
shaker with 250 μl of 1,200 μg/ml protein lysates at 4 °C
overnight, then with biotinylated anti-human IgG for
60 min and streptavidin-horseradish peroxidase (HRP)
conjugate for 30 min and visualized using a chemilumi-
nescence ECL kit (SuperSignal® West Pico Chemilumi-
nescent Kit; Thermo Scientific, Rockford, IL) for 10-
min in a Kodak Image Station 4,000 mm (Rochester,
NY). For semi-quantitative analysis, the ImageJ 1.45
software was used (http://rsbweb.nih.gov/ij/).
Immunohistochemistry
Tissue microarrays (TMA) including three cores of 2-
mm diameter from standard areas, two from the edges
of degraded and intact tumor border, and one from the
degraded center in each donor block were created from
the archived tissues using the semi-automated TMA
Master (3DHISTECH Ltd., Budapest, Hungary). For
antigen retrieval, dewaxed and rehydrated TMA slides
of 4-μm thickness were heated at ~100 °C for 40 min
using a microwave oven (Whirlpool, Benton Harbor,
MI) either with citrate buffer pH 0.6 (0.01-M sodium
citrate–citric acid; for HMGB1) or with Tris-EDTA (TE)
buffer pH 9.0 (0.1-M Trisbase and 0.01-M ethylenedi-
aminetetraacetic acid for all other antibodies) followed
by bovine serum albumin (BSA)–azide (5 %, Sigma-
Aldrich, St. Luis, MO) treatment for 20 min. Then,
sections were incubated in a humidity chamber at room
temperature for 16 h using the following antibodies:
polyclonal rabbit anti-human calreticulin (1:100),
Hsp70 (1:50), Hsp90 (1:100), and HMGB1 (1:200) (all
from Cell Signaling, Danvers, MA). These were then
detected using Alexa Fluor 546 (orange-red) coupled
anti-rabbit Ig (1:200) for 90 min. For slide washing,
0.1-M tris-buffered saline (pH 7.4) was used. Cell nu-
clei were stained blue using 4 ′ ,6-diamidino-2-
phenylindole (DAPI) and cell membranes were
highlighted using a wheat germ agglutinin alexa fluor
488 conjugate (1:200). All fluorescent probes were from
Invitrogen/Molecular Probes. Between incubation steps
the slides were washed in 0.1-M Tris-buffered saline
(pH 7.4) buffer.
Evaluation methods
Biomarker expression revealed by immunofluorescence
was evaluated using image (color, intensity, and size)
segmentation-based software HistoQuant (3DHISTECH).
Three to five representative annotations per tumor sec-
tion involving >1,000 cells each were tested. Relative
mask area (rMA) was calculated by dividing the stained
area with the whole annotation area except for
calreticulin staining, where membrane positive cells
were counted in 10 fields of views (FOV) in each core
at ×100 magnification. For analyzing protein expression
data related to a single time point that followed normal
distribution, the independent T test was used. For time
series data analysis, the Friedman test was used
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followed by the Wilcoxon post hoc test. The results
were significant at p<0.05.
Results
Messenger RNA expression was measured from pooled sam-
ples of the 4 h treated, 4 h untreated, and 24 h sham-treated
tumors, respectively. Modulated electrohyperthermia (EHT)
treatment induced significant up- or down-regulation of 48
transcripts of 39 genes compared to controls. Members of the
heat shock protein 70 family including HSPA1A, HSPA1B,
HSPA4, HSPA6, and HSPA8, and their co-chaperones
Hsp40 (DNAJB1 and DNAJB4) and Bag3 became up-
regulated. Hsp90 alpha (HSP90AA1) and Hsp60
(HSPD1) gene transcripts were also elevated upon
mEHT treatment (Fig. 1).
Apoptosis protein array testing of pooled lysates of 8-, 14-,
24 h-treated and 24 h sham-treated tumors also showed a
twofold increase of Hsp70 levels (1.92±0.027) at 8 h post-
treatment (Fig. 2a).
Modulated EHT-related tissue damage was character-
ized by a progressive destruction of the central tumor
area from 24 h post-treatment on surrounded by an
external rim of intact-looking tumor cells and a transi-
tional zone in between these two. Immunofluorescence
analysis revealed significantly elevated expression of
Hsp70 in the treated compared to the untreated group
(χ2 (19)=54.634, p<0.05). The post hoc test confirmed
the significant difference at 14-, 24-, 72-, and 120-h
post-treatment with a transitional decrement at 48 h.
At 14 h post-treatment Hsp70 protein was mainly asso-
ciated to the cytoplasmic membrane in the treated xe-
nografts. At later (72–120 h) stages Hsp70 upregulation
was observed only in the transient zone between the
morphologica l ly intac t and dead tumor areas
(Fig. 2b, c). Also, significantly increased Hsp90 levels
were detected (χ2 (21)=83.559, p<0.05) in the treated
compared to the untreated groups, which was confirmed
with the post hoc test at 24-, 48-, 72-, 120-, 168- and
216 h after mEHT treatment (Fig. 3) . Hsp90
translocated to the cytoplasm membrane only at later
time points (168- and 216 h post-treatment). In contrast
to Hsp70, Hsp90 levels showed continuous elevation in
the treated tumor cells between 24 and 216 h. Further-
more, the early accumulation of calreticulin to the cell
membrane was observed at 4 h (p=0.001) post-
treatment (Fig. 4).
HMGB1 protein was detected in cell nuclei up to 14 h, both
in the treated and in the untreated samples, followed by
cytoplasmic translocation at 24 h in the treated xenografts.
HMGB1 immunofluorescence disappeared 48 h post-
treatment in the damaged central areas of the treated tumors
Fig. 1 Heat map on gene
expression summarizing
transcripts showing significantly
differential expression 4 h after
mEHT treatment of HT29 colon
cancer xenografts. Arrows
highlight the elevated expression
(red boxes) of heat shock protein
genes from the Hsp70, Hsp40,
Hsp90, and Hsp60 families in the
treated samples (left column)
compared either to sham treated
(middle) and untreated samples
(right)
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while still prevailed in the untreated controls. In the treated
tumors nuclear HMGB1 protein was significantly lost (χ2
(19)=64.657, p<0.05) compared to the untreated group, as it
was also supported by the post-hoc test at each time point
between 24 and 216 h post-treatment (Fig. 5).
Discussion
Earlier, we detected mEHT-induced significant tumor
cell destruction as a result of the synergistic effects of
electric field and heat (Andocs et al. 2009a). This stress
caused caspase-independent programmed cell death
through Bax-mediated mitochondrial pore formation
and the concomitant release of cytochrome c and the
act ivat ion of apoptot ic inducing factor (AIF)
(Meggyeshazi et al. 2014). Here, we detected a charac-
teristic DAMP signal sequence in HT29 colorectal can-
cer xenografts upon mEHT treatment, which can poten-
tially induce an ICD response as it has been demon-
strated in diverse tumor models (D’Eliseo et al. 2013;
Garg et al. 2012).
Fig. 2 Abundance and localization of heat shock protein 70 (Hsp70) in
colorectal cancer xenografts measured with apoptosis protein array and
immunofluorescence (Alexa 564, red). a Pooled tissue samples reveal
elevated Hsp70 levels in apoptosis protein array at 8 h with no change at
14 and 24 h due to inhomogeneity of the tissue at these time points. b
Hsp70 immunofluorescence (Alexa 564, red), in 14-h post-mEHT treated
(a–e) and untreated (f–j) tumor cells also immunoreacted with wheat
germ agglutinin (Alexa 488, green) and DAPI to stain nuclei. In 14 h
post-mEHT-treated tumor cells Hsp70 immunofluorescence is predomi-
nately in cell membranes (arrows) as indicated by the wheat germ
agglutinin reactivity (arrowheads). In the untreated tumor cells Hsp70
immunofluorescence is predominately cytoplasmic. Scale bar=80 μm in
a and f, 10 μm in b and g, and 5 μm in c, d, e, h, i, and j. c Semi-
quantitative image analysis of immunofluorescence confirms significant
elevation of Hsp70 levels both between 14–24 h and 72–120 h post-
treatment (*p<0.05) with a decline at 48 h (rMA relative mask area)
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ICD requires antigen linked spatiotemporal DAMP
signals including the cell surface translocation of
calreticulin and heat shock proteins (Hsp70 and
Hsp90) followed by ATP liberation and the passive
release of HMGB1 protein from the nucleus during the
late apoptotic stage (D’Eliseo et al. 2013; Garg et al.
2012, 2013; Kepp et al. 2011; Kroemer et al. 2013;
Krysko et al. 2013; Ladoire et al. 2013).
Calreticulin, as a chaperone in the endoplasmic re-
ticulum (ER), interacts with ERp57 and calnexin and
supports proper protein folding and modulates calcium
signaling and homeostasis (Ladoire et al. 2013). In
tumor cell death-related immunogenicity, calreticulin
can translocate into lipid rafts of the plasma membrane
where it is called as ecto-calreticulin and serves as an
early “eat me” signal for antigen presenting dendritic
cells (Garg et al. 2013; Obeid et al. 2007). Upon
anthracyclin and ionizing radiation therapy, detection
of ecto-calreticulin was one of the first molecular
events of ICD-related DAMPs, occurring before any
morphological signs of apoptosis (Ladoire et al.
2013). In line with this, we detected ecto-calreticulin
as early as 4 h after mEHT treatment also preceding
programmed cell death signals, which later we saw first
at 8-h post-treatment in the same HT29 xenograft mod-
el (Meggyeshazi et al. 2014).
Heat shock proteins are a family of conserved chap-
erones induced by cell stress including oxidative stress,
irradiation, chemotherapeutic drugs, and heat and elec-
tromagnetic field (Blank and Goodman 2009; Horvath
and Vigh 2010; Robert 2003). Tumors frequently show
elevated Hsp70 levels (Multhoff and Hightower 2011).
In the cytoplasm, overexpressed Hsp70 can inhibit apo-
ptosis and act as a cytoprotector (Horvath and Vigh
2010) maintaining protein homeostasis (Gehrmann
et al. 2008). However, treatments using oxaliplatin, γ-
radiation, anthracyclines, epidermal growth factor
receptor-specific antibody or hypericin-based photody-
namic therapy can trigger the cell membrane accumula-
tion of heat shock proteins (Kroemer et al. 2013;
Krysko et al. 2013) as a part of the spatiotemporal
DAMP signals and promote anti-tumor T cell response
(Garg et al. 2013). Besides the immunogenicity of cell
membrane Hsp70 (Gehrmann et al. 2008), extracellular
heat shock proteins can directly boost the innate im-
mune response (Calderwood et al. 2007; Multhoff and
Hightower 2011). In this study, mEHT-related cell mem-
brane accumulation of Hsp70 was observed from 14 h
post-treatment with two peaks at 24 h and 72 h with a
decrement at 48 h. The second peak was most probably
associated with soluble factors released from damaged
cells. Similar double peaks in Hsp70 levels (at 12 and
72 h) were seen by others in bladder cancer cells
treated with capsaicin-inducing ICD through a DAMP
sequence (D’Eliseo et al. 2013). On the other hand, cell
membrane Hsp70 was also linked with the protection of
membrane integrity under stress conditions (Horvath and
Vigh 2010). Therefore, in tumor therapy, cell surface
Hsp70 positivity has been associated both with negative
prognosis, e.g., in lower rectal carcinomas and in squa-
mous cell carcinoma of the lung (Gehrmann et al. 2008;
Pfister et al. 2007) and also, with improved outcome,
e.g., in gastric and colon carcinomas (Pfister et al.
Fig. 3 Hsp90 immunofluorescence (Alexa 564, red) and semi-quantita-
tive analysis of heat shock protein 90 (Hsp90) in post-mEHT treated and
untreated colorectal cancer xenografts. a Hsp90 immunofluorescence is
predominately cytoplasmic at 24 h (a) and associated with cell mem-
branes at 168 h post-mEHT (b; arrows), and as shown in the inset. Hsp90
immunofluorescence is less apparent at 24 h (c) and at 168 h (d) in
untreated tumor cells. Cell nuclei are stained blue (DAPI). Scale bar=
60 μm in all and 20 μm in the inset. bGraph showing significant increase
of Hsp90 protein between 24 and 216 h in the treated compared to the
untreated tumor cells in the morphologically intact tumor areas (*p<0.05)
(rMA relative mask area)
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2007). This latter is in line with our findings in HT29
colon cancer xenografts where mEHT treatment resulted
in tumor cell death.
Membrane associated Hsp90 can also be a member
of DAMP sequence linked to ICD, e.g., upon epidermal
growth factor receptor antibody therapy and hypericin-
based photodynamic therapy (Garg et al. 2013). Similar
to that found by others upon hypericin phototherapy and
capsaicin-induced DAMP signals, we also detected the
cell membrane accumulation and late apoptotic release
of Hsp90 from 168 h post-mEHT treatment (D’Eliseo
et al. 2013; Garg et al. 2013).
HMGB1 represents a late signal of ICD with diverse
roles. In the nucleus, it acts as a non-histone chromatin
binding protein interacting with the minor groove of
DNA and regulatory molecules such as p53, NF-κB,
and steroid hormone receptors (Guo et al. 2013; Kepp
et al. 2011; Ladoire et al. 2013). Upon cell stress,
HMGB1 is released either from necrotic or apoptotic
cells (D’Eliseo et al. 2013). Extracellular HMGB1 can
be a cytokine-like activator of macrophages, a
chemotactant for neutrophils and a promoter of dendritic
cell maturation through toll-like receptors (TLR2/4)
(Guo e t a l . 2013) . However, ep igene t i c and
posttranslational modifications may attenuate the pro-
inflammatory activity of HMGB1 (Guo et al. 2013).
We detected the cytoplasmic release of HMGB1 protein
at 24 h and its clearance from mEHT treated carcinoma
cells by 48-h post-treatment, which has the potential to
contribute both to the innate and T cell immune
responses.
Elevated glycolysis in tumor cells, known as the
Warburg effect, can increase permittivity and conductiv-
ity (Andocs et al. 2009b; Blad and Baldetorp 1996;
Blad et al. 1999; Fiorentini and Szasz 2006; Zou and
Guo 2003), which support mEHT to selectively damage
tumor cells (Andocs et al. 2009a) without affecting
normal tissues. The electric field and heat can induce
cellular stress signals (Balogh et al. 2013) leading to
Bax-mediated mitochondrial dysfunction, pore forma-
tion, and programmed cell death (Meggyeshazi et al.
2014). The benefit of mEHT that it can locally induce
DAMP signals without the systemic damage of immune
cells caused by traditional ICD inducer chemotherapies,
especially if steroids are also part of the therapy (Garg
et al. 2013).
The ultimate outcome of immune response to cancer
cell death is rather complex and context dependent. Cell
Fig. 4 Calreticulin immunofluorescence (Alexa 564, red) and semi-
quantitative analysis of calreticulin in post-mEHT treated and untreated
colorectal cancer xenografts. a Calreticulin immunofluorescence is local-
ized to the cell membranes 4 h post-mEHT (arrows; a–e) before any
morphological or molecular sign of programmed cell death. Calreticulin
immunofluorescence is diffuse and cytoplasmic in untreated tumor cells
(f–j). Cells nuclei are stained blue (DAPI). Scale bar=60 μm in a, b, c, f,
g, and h and 10 μm in d, e, i, and j. bGraph showing the mean number of
cytoplasmic membrane positive cells counted at ×100magnification in 10
fields of views (FOV) of five parallel samples. Elevation of calreticulin
cell membrane immunofluorescence is highly significant (**p<0.01) in
4 h post-mEHT treated compared to untreated tumor cells (FOV field of
view)
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death is influenced by the type and localization/
microenvironment of cancer cells, the cell death path-
ways activated, the type of immune cells interacting with the
cancer, and the efficiency of the recognition of cancer antigens
(Garg et al. 2013). Though our results cannot be linked direct-
ly to ICD, detection of DAMP signals in colon cancer sup-
ports the feasibility of testing if mEHT treatment can directly
promote ICD in tumors raised in immune competent animals.
Fig. 5 HMGB1 immunofluorescence (Alexa 564, red) and semi-quanti-
tative analysis of HMGB1 post-mEHT treated and untreated colorectal
cancer xenografts. a HMGB1 immunofluorescence shows normal nucle-
ar localization up to 14 h post-mEHT treated (a) and untreated (d) tumor
cells. HMGB1 immunofluorescence is diffuse and diminished in 24 h and
not evident in 48 h post-mEHT treated (b and c, respectively) tumor cells
but not changed in 24 and 48 h untreated (e and f, respectively) tumor
cells. Boxes show the location of the high-magnification insets. Circles in
the insets show the location of nuclei. Scale bar=60μm in a, b, c, d, e and
f, and 25 μm in all insets. b Semi-quantitative analysis highlights signif-
icant reduction of HMGB1 immunofluorescence between 48 and 216 h
post-mEHT treated compared to untreated tumor cells (*p<0.05) (rMA
relative mask area)
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In conclusion, based on sporadic observations of
earlier in vitro studies of local hyperthermia (Frey
et al. 2012; Mantel et al. 2010; Schildkopf et al.
2010), here, we showed, in vivo, that mEHT induced
tumor cell stress can generate the spatiotemporal se-
quence of DAMP signals in colorectal cancer without
any additional genetic or pharmaceutical intervention.
Our data suggest that mEHT can be a potential local
inducer of ICD, without a systemic interference with
immune functions, which need to be investigated further
in immune competent animal models.
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